310
Views
17
CrossRef citations to date
0
Altmetric
Original Research

Screening of peripheral arterial disease in primary health care

, , , , , & show all
Pages 355-363 | Published online: 20 Aug 2019

References

  • Aboyans V, Ricco J-B, Bartelink M-LE-L, et al. ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur Heart J. 2017;2018(39):763–816.
  • Criqui MH, Denenberg JO, Langer RD, Fronek A. The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med. 1997;2:221–226. doi:10.1177/1358863X97002003109546971
  • Ness J, Aronow WS. Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospital-based geriatrics practice. J Am Geriatr Soc. 1999;47:1255–1256. doi:10.1111/j.1532-5415.1999.tb05208.x10522961
  • European Stroke Organisation, Tendera M, Aboyans V, et al. ESC guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries * The task force on the diagnosis and treatment of peripheral artery diseases of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(22):2851–2906.21873417
  • Criqui MH. Peripheral arterial disease - epidemiological aspects. Vasc Med. 2001;6:3–7. doi:10.1177/1358836X0100600i102
  • Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the united states: results from the national health and nutrition examination survey, 1999-2000. Circulation. 2004;110:738–743. doi:10.1161/01.CIR.0000137913.26087.F015262830
  • Farkas K, Járai Z, Kolossváry E, Ludányi A, Clement DL, Kiss I. High prevalence of peripheral arterial disease in hypertensive patients: the evaluation of ankle-brachial index in hungarian hypertensives screening program. J Hypertens. 2012;30:1526–1532. doi:10.1097/HJH.0b013e3283559a6a22743684
  • Kolossváry E, Bánsághi Z, Szabó GV, et al. A diabeteses láb ischaemiás eredete. Epidemiológia, a diagnózis nehézségei, prevenciós és revascularisatiós lehetőségek.[The background of the diabetic ischaemic foot. Epidemiology, difficulties in diagnosis, prevention and revascularisation options] Orvosi Hetilap. 2017;158:203–211.
  • Eurostat regional yearbook 2018 [Internet]. 2018 Available from: https://ec.europa.eu/eurostat/documents/3217494/9210140/KS-HA-18-001-EN-N.pdf/655a00cc-6789-4b0c-9d6d-eda24d412188. Accessed 722, 2019
  • Leng GC, Fowkes FG. The Edinburgh claudication questionnaire: an improved version of the WHO/rose questionnaire for use in epidemiological surveys. J Clin Epidemiol. 1992;45:1101–1109.1474406
  • Lijmer JG, Hunink MG, van den Dungen JJ, et al. ROC analysis of noninvasive tests for peripheral arterial disease. Ultrasound Med Biol. 1996;22:391–398.8795165
  • Diehm C. Association of low ankle brachial index with high mortality in primary care. Eur Heart J. 2006;27:1743–1749. doi:10.1093/eurheartj/ehl09216782720
  • Wild SH, Byrne CD, Smith FB, et al. Low ankle-brachial pressure index predicts increased risk of cardiovascular disease independent of the metabolic syndrome and conventional cardiovascular risk factors in the Edinburgh artery study. Diabetes Care. 2006;29:637–642. doi:10.2337/diacare.29.03.06.dc05-163716505519
  • Yap Kannan R, Dattani N, Sayers RD, et al. Survey of ankle–brachial pressure index use and its perceived barriers by general practitioners in the UK. Postgrad Med J. 2016;92:322–327. doi:10.1136/postgradmedj-2015-13337526846131
  • Davies JH, Kenkre J, Williams EM. Current utility of the ankle-brachial index (ABI) in general practice: implications for its use in cardiovascular disease screening. BMC Fam Pract. [Internet] 2014;15(1): 69 Available from: http://bmcfampract.biomedcentral.com/articles/10.1186/1471-2296-15-69. [cited 2018 Jul 22].24742018
  • Fowkes FGR, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382:1329–1340. doi:10.1016/S0140-6736(13)61249-023915883
  • Price JF, Mowbray PI, Lee AJ, et al. Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: edinburgh artery study. Eur Heart J. 1999;20:344–353. doi:10.1053/euhj.1998.119410206381
  • Powell JT, Edwards RJ, Worrell PC, et al. Risk factors associated with the development of peripheral arterial disease in smokers: a case-control study. Atherosclerosis. 1997;129:41–48. doi:10.1016/s0021-9150(96)06034-09069515
  • Tombor I, Paksi B, Urbán R, et al. Epidemiology of smoking in the hungarian population, based on national representative data. Clin Exp Med J. 2011;5:27–37. doi:10.1556/CEMEd.4.2010.28817
  • Ingolfsson IO, Sigurdsson G, Sigvaldason H, Thorgeirsson G, Sigfusson N. A marked decline in the prevalence and incidence of intermittent claudication in Icelandic men 1968-1986: a strong relationship to smoking and serum cholesterol–the Reykjavik study. J Clin Epidemiol. 1994;47:1237–1243. doi:10.1016/0895-4356(94)90128-77722559
  • Hiatt WR, Hoag S, Hamman RF. Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis valley diabetes study. Circulation. 1995;91:1472–1479. doi:10.1161/01.cir.91.5.14807867189
  • Jude EB, Oyibo SO, Chalmers N, et al. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care. 2001;24:1433–1437. doi:10.2337/diacare.24.2.35011473082
  • Murabito JM, D’Agostino RB, Silbershatz H, Wilson PWF. Intermittent claudication. A risk profile from the framingham heart study. Circulation. 1997;96:44–49. doi:10.1161/01.CIR.96.1.449236415
  • Hooi JD, Stoffers HE, Kester AD, et al. Risk factors and cardiovascular diseases associated with asymptomatic peripheral arterial occlusive disease. The limburg PAOD study. Peripheral arterial occlusive disease. Scand J Prim Health Care. 1998;16:177–182. doi:10.1080/0281343987500031429800232
  • Sanderson K. Lipid peroxidation of circulating low density lipoproteins with age, smoking and in peripheral vascular disease. Atherosclerosis. 1995;118:45–51. doi:10.1016/0021-9150(95)05591-J8579630
  • Horby J, Grande P, Vestergaard A, Grauholt AM. High density lipoprotein cholesterol and arteriography in intermittent claudication. Eur J Vasc Surg. 1989;3:333–337.2767255
  • Bradby GV, Valente AJ, Walton KW. Serum high-density lipoproteins in peripheral vascular disease. Lancet. 1978;2:1271–1274. doi:10.1016/S0140-6736(78)92038-X82779
  • Seshadri S, Beiser A, Pikula A, et al. Parental occurrence of stroke and risk of stroke in their children: the framingham study. Circulation. 2010;121:1304–1312. doi:10.1161/CIRCULATIONAHA.109.85424020212282
  • Valentine RJ, Verstraete R, Clagett GP, Cohen JC. Premature cardiovascular disease is common in relatives of patients with premature peripheral atherosclerosis. Arch Intern Med. 2000;160:1343–1348. doi:10.1001/archinte.160.9.134310809039
  • Prushik SG, Farber A, Gona P, et al. Parental intermittent claudication as risk factor for claudication in adults. Am J Cardiol. 2012;109:736–741. doi:10.1016/j.amjcard.2011.10.03222154319